↓ Skip to main content

Precision medicine phase II study evaluating the efficacy of a double immunotherapy by durvalumab and tremelimumab combined with olaparib in patients with solid cancers and carriers of homologous…

Overview of attention for article published in BMC Cancer, August 2020
Altmetric Badge

About this Attention Score

  • Above-average Attention Score compared to outputs of the same age (55th percentile)
  • Good Attention Score compared to outputs of the same age and source (73rd percentile)

Mentioned by

policy
1 policy source

Citations

dimensions_citation
37 Dimensions

Readers on

mendeley
81 Mendeley